公司资料
Certara 股价、新闻与催化剂
- 股票代码:
- CERT
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
8.00 USD (0.00%)
收盘价
最后更新: 2026年8月17日
874M USD
市值
股价为何变动
As of Aug 17, 2026, CERT was little changed and closed at $8.00. No new same-company headline was identified in the current news window.
公司概览
Model-Informed Drug Development
Certara provides biosimulation software and technology-enabled services used throughout drug discovery, clinical development and regulatory review. Its tools help predict how medicines behave in different patients and dosing scenarios.
Software Portfolio
The company's software includes pharmacokinetic, pharmacodynamic, quantitative-systems-pharmacology and clinical-trial simulation applications. Customers use these products to inform dose selection, study design and regulatory submissions. Certara serves pharmaceutical and biotechnology companies, academic institutions and regulators. Its business combines recurring software subscriptions with scientific consulting and implementation services.
未来催化剂
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。